Webb30 aug. 2024 · The FDA's Drug Review Process: Ensuring Drugs Are Safe and Effective Think It Through: Managing the Benefits and Risks of Medicines Contact FDA For More Info 855-543-DRUG (3784) and press 4... Webb1 apr. 2024 · Simvastatin is used together with a proper diet to treat high cholesterol and triglyceride (fat) levels in the blood. This medicine may help prevent medical problems (eg, heart or blood vessel problems, heart attacks, or strokes) caused by clogged blood vessels. Simvastatin may also be used to prevent certain types of heart problems ...
Simvastatin: MedlinePlus Drug Information
Webb13 mars 2024 · Fenofibrate is FDA approved to treat patients with hypertriglyceridemia, primary hypercholesterolemia, or mixed dyslipidemia. It reduces low-density lipoprotein cholesterol (LDL-C), total cholesterol, triglycerides, and apolipoprotein B and increases high-density lipoprotein cholesterol (HDL-C) in adults. Fenofibrate should be used in … Webb20 juli 2024 · Simvastatin may also be used to decrease the amount of cholesterol and other fatty substances in the blood in children and teenagers 10 to 17 years of age who have familial heterozygous hypercholesterolemia (an inherited condition in which cholesterol cannot be removed from the body normally). early carriages and roads
Simvastatin for management of polycystic ovary syndrome (PCOS)
WebbSimvastatin is one of the most widely prescribed drugs for the treatment of hypercholesterolaemia, hyperlipidemia and coronary artery disease. There are conflicting statements regarding the timing of simvastatin administration, and convincing experimental evidence remains unavailable. Webb30 aug. 2024 · Zocor (simvastatin): 20 to 40 mg daily; Low-intensity, aiming for an LDL reduction of less than 30%: ... Hyperlipidemia is treated by diet and lifestyle changes. If these do not reduce cholesterol and triglycerides to an acceptable level, medication such as a statin may be prescribed as well. Webb12 nov. 2013 · Scandinavian Simvastatin Survival Study (4S) • Double-blind trial in 4444 men and women 35 to 70 years of age with prior MI and/or angina pectoris and total cholesterol (TC) of 212-309 mg/dL • Randomized to simvastatin 20 mg daily or placebo; simvastatin increased to 40 mg daily if TC > 200 mg/dL • Median duration was 5.4 years css winform